SUBSCRIBE
SUBSCRIBE
Kate Goodwin

Kate Goodwin

Contributing Writer | News & Features

Kate Goodwin hails from a background primarily in marketing. A passion for health sciences and writing led her to the biopharma news world, and she’s never looked back. She’s been writing for BioSpace for more than two years with a focus on cutting edge research, Alzheimer’s disease and pediatrics. Her free time is filled by her husband, children, Beagles, books, crochet and creative writing. She can be reached at kate.goodwin@biospace.com.

Business
Money on the Move: February 24 – March 2
With the overflow of investments into life sciences, who has time to keep up? Find your weekly snapshot of where the cash is headed in this week’s Money on the Move.
March 2, 2021
 · 
8 min read
 · 
Kate Goodwin
Justin Sullivan/Getty Images
Deals
Agilent Adds Liquid Biopsy Assay to Diagnostic Tool Bag with $550 Million Buy
If Resolution hits specified milestones, it’ll scoop up an extra $145 million from Agilent.
March 2, 2021
 · 
2 min read
 · 
Kate Goodwin
Deals
Beijing CRMO Further Expands UK Footprint with Abbvie’s Allergan Site
Beijing-based CRMO Pharmaron has accomplished impressive global growth via acquisitions over the past eight months.
March 1, 2021
 · 
2 min read
 · 
Kate Goodwin
Nathan Stirk/Getty Images
Drug Development
AstraZeneca, Amgen Breathing Easier with Optimistic Phase III Asthma Drug Results
After announcing a successful primary endpoint in November, AstraZeneca and Amgen presented the full data on their severe asthma antibody candidate on Friday.
February 26, 2021
 · 
3 min read
 · 
Kate Goodwin
Fabrice Chouraqui, CEO of Cellarity
Business
Cellarity Takes in $123 Million to Drive Cell-Centric Drug Discovery Toward Clinic
The company uses computational modeling of cell behavior to treat disease, instead of going after a molecular target, redefining drug discovery through its cell-centric approach.
February 25, 2021
 · 
2 min read
 · 
Kate Goodwin
Business
Money on the Move: February 17-23
Life sciences companies across the globe are raking in investment dollars to advance drug programs.
February 23, 2021
 · 
5 min read
 · 
Kate Goodwin
6 Tips for Advancing Your Career While Working from Home
Your career shouldn’t have to stay in a holding pattern just because you’re not at the office.
February 23, 2021
 · 
5 min read
 · 
Kate Goodwin
Deals
Catalent Expands Plasmid Capabilities with Delphi Acquisition
CDMO Catalent continues its push to the top with yet another acquisition. Buying out Delphi Genetics, the manufacturing company can now add plasmid DNA production to its growing list of offerings.
February 23, 2021
 · 
2 min read
 · 
Kate Goodwin
Drug Development
Genentech Could Regain the Blindness-Related Disease Market with New Treatment
After announcing topline data from two identical Phase III trials, Roche’s Genentech has doubled down on data and are now showing positive results from four studies for its newest blindness-fighting treatment.
February 12, 2021
 · 
2 min read
 · 
Kate Goodwin
Aleksander Kalka/NurPhoto via Getty Images
Policy
Fresenius Kabi Hid “Dirty Laundry” from FDA, Pleads Guilty to Criminal Charges
The cancer drugmaker pled guilty of violating the Federal Food, Drug and Cosmetic Act by failing to provide certain records to investigators in federal court.
February 11, 2021
 · 
2 min read
 · 
Kate Goodwin
BioCapital
Money on the Move: February 3-9
The cash just keeps coming for biopharma companies. Here’s a rundown of some of this week’s investment dollar recipients.
February 9, 2021
 · 
6 min read
 · 
Kate Goodwin
BigHat BioScience’s founders – CEO Mark DePristo a
Business
BigHat Plans to Take Antibody Engineering to a Whole New Level
BigHat is a Bay-area startup that’s reimagining antibody development with the help of AI and ML (machine learning) technologies through data-driven discovery.
February 9, 2021
 · 
5 min read
 · 
Kate Goodwin
Drug Development
Are Two Better Than One? Expert Weighs in on Double Masking
Ever since Dr. Fauci said he often double masks and that two masks “just makes common sense,” the medical community has been in somewhat of a debate with many in agreement, and some saying the opposite.
February 9, 2021
 · 
5 min read
 · 
Kate Goodwin
Nautilus founders Sujal Patel (left) and Parag Mal
Deals
Fast Track to NASDAQ - Nautilus Uses SPAC to go Public
According to NASDAQ, SPACs – Special Purpose Acquisition Companies – now make up more than a third of all IPOs.
February 9, 2021
 · 
2 min read
 · 
Kate Goodwin
Job Trends
Life Sciences Job Expansions Continue to Soar Throughout Pandemic
Here’s a recap of companies announcing facility expansions this past month and life sciences job creations across the nation.
February 9, 2021
 · 
4 min read
 · 
Kate Goodwin
Load More